2010 versus the 2000 consensus criteria in patients with normalised insulin‐like growth factor 1 after transsphenoidal surgery has high predictive values for long‐term recurrence‐free survival in acromegaly - Shen - 2021

Endocrine aspects of metabolic dysfunction-associated steatotic liver disease (MASLD): Beyond insulin resistance - Journal of Hepatology

PDF) Contemporary Management of Acromegaly: A Practical Approach

Chapters Archive - Page 11 of 44 - Endotext

Frontiers Role of Somatostatin Receptor in Pancreatic Neuroendocrine Tumor Development, Diagnosis, and Therapy

Elevated insulin‐like growth factor‐1 in patients without clinical evidence of acromegaly - Careless - 2023 - Clinical Endocrinology - Wiley Online Library

Acromegaly - ScienceDirect

PDF) Updates in Diagnosis and Treatment of Acromegaly

Long-term outcomes of transsphenoidal surgery for management of growth hormone–secreting adenomas: single-center results in: Journal of Neurosurgery Volume 133 Issue 5 (2019) Journals

Somatostatin analogues in acromegaly and gastroenteropancreatic neuroendocrine tumours: past, present and future in: Endocrine-Related Cancer Volume 23 Issue 12 (2016)

Acromegaly - ScienceDirect

Outcomes of pituitary surgery for Cushing's disease: a systematic review and meta-analysis

Assessment of sFRP4 as a bio-marker for predicting aggressiveness and recurrence of growth hormone-secreting pituitary adenomas

Characteristics of Gut Microbiota in Patients with GH-Secreting Pituitary Adenoma

PDF) Treatment of Acromegaly by Rosiglitazone via up-regulating 15-PGDH in Both Pituitary Adenoma and Liver